{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:13:04Z","timestamp":1789776784050,"version":"4.0.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Grant in Aid for Scientific Research","award":["18K07807"],"award-info":[{"award-number":["18K07807"]}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP19ek0109330"],"award-info":[{"award-number":["JP19ek0109330"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Patients with chronic granulomatous disease (CGD) develop severe infections, including Bacillus Calmette-Gu\u00e9rin (BCG). Although the autosomal recessive CGD (AR-CGD) patients should hypothetically develop relatively fewer infections compared to the X-linked CGD (X-CGD) patients due to more residual reactive oxygen intermediates, the impacts of BCG vaccination on AR-CGD and X-CGD patients are unclear. Herein, we demonstrated the clinical features of BCG infections, treatments, and genetic factors in CGD patients after BCG vaccination under the Japanese immunization program.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We collected data retrospectively from 43 patients with CGD and assessed their history of initial infection, age at diagnosis of CGD, BCG vaccination history, clinical course, treatment for BCG infections, and genetic mutations associated with CGD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Fourteen CGD patients avoided BCG vaccination because of other preceding infections and family history. Of 29 patients with CGD who received BCG vaccination, 20 patients developed BCG infections. Although the age at onset of initial infection in X-CGD patients was significantly younger than that in AR-CGD patients (P\u2005&amp;lt;\u2005.01), the onset and frequency of BCG infections were similar in X-CGD and AR-CGD patients. In X-CGD patients, BCG infections equally developed in the patients carrying missense, insertion, deletion, nonsense, and splice mutations of CYBB. All CGD patients with BCG infections were successfully treated with anti-tuberculous drugs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Although X-CGD patients develop severe infections at a younger age than AR-CGD patients, our data suggested that BCG infections develop at high frequency in both AR-CGD and X-CGD patients, regardless of genotype and mutant forms.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciaa1049","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T19:22:47Z","timestamp":1595445767000},"page":"e2538-e2544","source":"Crossref","is-referenced-by-count":8,"title":["Bacillus Calmette-Gu\u00e9rin (BCG) Infections at High Frequency in Both AR-CGD and X-CGD Patients Following BCG Vaccination"],"prefix":"10.1093","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0247-7729","authenticated-orcid":false,"given":"Takashi","family":"Ishikawa","sequence":"first","affiliation":[{"name":"Division of Immunology, National Center for Child Health and Development, Tokyo, Japan"},{"name":"Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Okai","sequence":"additional","affiliation":[{"name":"Division of Immunology, National Center for Child Health and Development, Tokyo, Japan"},{"name":"Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Mochizuki","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, National Center for Child Health and Development, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"Division of Immunology, National Center for Child Health and Development, Tokyo, Japan"},{"name":"Department of Human Genetics, National Center for Child Health and Development, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Onodera","sequence":"additional","affiliation":[{"name":"Division of Immunology, National Center for Child Health and Development, Tokyo, Japan"},{"name":"Department of Human Genetics, National Center for Child Health and Development, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinao","family":"Kawai","sequence":"additional","affiliation":[{"name":"Division of Immunology, National Center for Child Health and Development, Tokyo, Japan"},{"name":"Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,30]]},"reference":[{"key":"2021110300070805300_CIT0001","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jinf.2014.07.013","article-title":"Recent advances in chronic granulomatous disease","volume":"69","author":"Goldblatt","year":"2014","journal-title":"J Infect"},{"key":"2021110300070805300_CIT0002","first-page":"199","article-title":"Phagocyte NADPH oxidase: a multicomponent enzyme essential for host defenses","volume":"53","author":"El-Benna","year":"2005","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"2021110300070805300_CIT0003","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.bcmd.2010.01.009","article-title":"Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update)","volume":"44","author":"Roos","year":"2010","journal-title":"Blood Cells Mol Dis"},{"key":"2021110300070805300_CIT0004","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/cei.12202","article-title":"Molecular diagnosis of chronic granulomatous disease","volume":"175","author":"Roos","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"2021110300070805300_CIT0005","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMicm1106350","article-title":"Images in clinical medicine: chronic granulomatous disease","volume":"367","author":"Esfandbod","year":"2012","journal-title":"N Engl J Med"},{"key":"2021110300070805300_CIT0006","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jaci.2007.04.034","article-title":"BCG-osis and tuberculosis in a child with chronic granulomatous disease","volume":"120","author":"Bustamante","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"2021110300070805300_CIT0007","first-page":"65","article-title":"[Clinical analysis of 18 children with disseminated bacille Calmette-Gu\u00e9rin infection]","volume":"48","author":"Li","year":"2010","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"2021110300070805300_CIT0008","first-page":"380","article-title":"[Clinical features of chronic granulomatous disease]","volume":"50","author":"Ying","year":"2012","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"2021110300070805300_CIT0009","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/cyto.990180306","article-title":"Evaluation of flow cytometric methods for diagnosis of chronic granulomatous disease variants under routine laboratory conditions","volume":"18","author":"Emmend\u00f6rffer","year":"1994","journal-title":"Cytometry"},{"key":"2021110300070805300_CIT0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0022-1759(94)00247-T","article-title":"Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes","volume":"178","author":"Vowells","year":"1995","journal-title":"J Immunol Methods"},{"key":"2021110300070805300_CIT0011","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1164\/ajrccm.157.5.9709068","article-title":"Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease","volume":"157","author":"van \u2018t Hek","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"2021110300070805300_CIT0012","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1056\/NEJMoa1007097","article-title":"Residual NADPH oxidase and survival in chronic granulomatous disease","volume":"363","author":"Kuhns","year":"2010","journal-title":"N Engl J Med"},{"key":"2021110300070805300_CIT0013","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fimmu.2019.00073","article-title":"Genetic and clinical profiles of disseminated Bacillus Calmette-Gu\u00e9rin disease and chronic granulomatous disease in China","volume":"10","author":"Li","year":"2019","journal-title":"Front Immunol"},{"key":"2021110300070805300_CIT0014","doi-asserted-by":"crossref","first-page":"e94485","DOI":"10.1371\/journal.pone.0094485","article-title":"Clinical characteristics and immunogenetics of BCGosis\/BCGitis in Chinese children: a 6 year follow-up study","volume":"9","author":"Ying","year":"2014","journal-title":"PLoS One"},{"key":"2021110300070805300_CIT0015","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1128\/jcm.35.3.566-569.1997","article-title":"PCR identification of Mycobacterium bovis BCG","volume":"35","author":"Talbot","year":"1997","journal-title":"J Clin Microbiol"},{"key":"2021110300070805300_CIT0016","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jaci.2013.05.039","article-title":"Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients","volume":"132","author":"K\u00f6ker","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"2021110300070805300_CIT0017","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/cmi.12322","article-title":"Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections","volume":"16","author":"Deffert","year":"2014","journal-title":"Cell Microbiol"},{"key":"2021110300070805300_CIT0018","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ni.1992","article-title":"Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease","volume":"12","author":"Bustamante","year":"2011","journal-title":"Nat Immunol"},{"key":"2021110300070805300_CIT0019","doi-asserted-by":"crossref","first-page":"e1004325","DOI":"10.1371\/journal.ppat.1004325","article-title":"Bacillus Calmette-Guerin infection in NADPH oxidase deficiency: defective mycobacterial sequestration and granuloma formation","volume":"10","author":"Deffert","year":"2014","journal-title":"PLoS Pathog"},{"key":"2021110300070805300_CIT0020","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1007\/s12325-017-0636-2","article-title":"A review of chronic granulomatous disease","volume":"34","author":"Arnold","year":"2017","journal-title":"Adv Ther"},{"key":"2021110300070805300_CIT0021","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/INF.0b013e318194cf09","article-title":"Family clusters of variant X-linked chronic granulomatous disease","volume":"28","author":"Bender","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"2021110300070805300_CIT0022","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1056\/NEJMra1413919","article-title":"Treatment of tuberculosis","volume":"373","author":"Horsburgh","year":"2015","journal-title":"N Engl J Med"},{"key":"2021110300070805300_CIT0023","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.0736-8046.2004.21606.x","article-title":"Lymphadenopathy after BCG vaccination in a child with chronic granulomatous disease","volume":"21","author":"Vieira","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"2021110300070805300_CIT0024","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1442-200X.2007.02383.x","article-title":"Hazards of early BCG vaccination: BCGitis in a patient with chronic granulomatous disease","volume":"49","author":"Kawashima","year":"2007","journal-title":"Pediatr Int"},{"key":"2021110300070805300_CIT0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10875-008-9243-y","article-title":"First report of clinical, functional, and molecular investigation of chronic granulomatous disease in nine Jordanian families","volume":"29","author":"Bakri","year":"2009","journal-title":"J Clin Immunol"},{"key":"2021110300070805300_CIT0026","first-page":"133","article-title":"Disseminated Mycobacterium bovis infection after BCG vaccination","volume":"5","author":"Afshar Paiman","year":"2006","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"2021110300070805300_CIT0027","doi-asserted-by":"crossref","first-page":"MGM2","DOI":"10.1128\/microbiolspec.MGM2-0028-2013","article-title":"BCG vaccines","volume":"2","author":"Tran","year":"2014","journal-title":"Microbiol Spectr"},{"key":"2021110300070805300_CIT0028","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/pbc.20455","article-title":"Chronic granulomatous disease in Latin American patients: clinical spectrum and molecular genetics","volume":"46","author":"Agudelo-Fl\u00f3rez","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"2021110300070805300_CIT0029","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/INF.0b013e31815b494c","article-title":"Susceptibility to mycobacterial infections in children with X-linked chronic granulomatous disease: a review of 17 patients living in a region endemic for tuberculosis","volume":"27","author":"Lee","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"2021110300070805300_CIT0030","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1824-7288-35-42","article-title":"Immunologic aspects of patients with disseminated bacille Calmette-Guerin disease in north-west of Iran","volume":"35","author":"Sadeghi-Shanbestari","year":"2009","journal-title":"Ital J Pediatr"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa1049\/34156873\/ciaa1049.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/9\/e2538\/41060706\/ciaa1049.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/9\/e2538\/41060706\/ciaa1049.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:08:54Z","timestamp":1635898134000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/73\/9\/e2538\/5876589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,30]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9,30]]},"published-print":{"date-parts":[[2021,11,2]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa1049","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11,1]]},"published":{"date-parts":[[2020,9,30]]}}}